Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges

This review focuses on the molecular glycovaccine concept, a promising option to develop a Shigella glycoconjugate vaccine. Subsequent to original developments involving, as main vaccine component, the detoxified Shigella lipopolysaccharide randomly conjugated at multiple sites to a carrier protein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Phalipon, Armelle, Mulard, Laurence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954881/
https://www.ncbi.nlm.nih.gov/pubmed/35335035
http://dx.doi.org/10.3390/vaccines10030403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954881/
https://www.ncbi.nlm.nih.gov/pubmed/35335035
http://dx.doi.org/10.3390/vaccines10030403

Ejemplares similares